The Supreme Court has ruled to keep the abortion pill mifepristone available via telehealth while a lawsuit from Louisiana proceeds. - The Court stayed a 5th Circuit ruling that would have banned mailing mifepristone nationwide.
- Justices Alito and Thomas dissented from the order. - The FDA had determined in-person dispensing was medically unnecessary in 2021.
- FDA Commissioner Dr. Marty Makary resigned this week under White House pressure.
This decision maintains current access to medication abortion via telemedicine for now.